Apellis Pharmaceuticals, Inc.

This study tested the safety of a new, easier-to-use prefilled syringe for delivering pegcetacoplan injections into the eye. It involved 44 older adults with geographic atrophy, a form of age-related macular degeneration that causes progressive vision loss. The main goal was to s…

This Phase 3 study tested whether pegcetacoplan injections could help people with rare kidney diseases called C3 glomerulopathy (C3G) or immune-complex membranoproliferative glomerulonephritis (IC-MPGN). The trial involved 124 participants who received either the actual drug or p…

This study followed people for up to three years to see if regular injections of the drug pegcetacoplan into the eye are safe and can continue to slow the progression of geographic atrophy, a form of advanced age-related macular degeneration that causes permanent vision loss. It …